Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
Story Views
Now:
Last hour:
Last 24 hours:
Total:

NII Holdings Inc. Stock Surges on PRIP™ Prospects (NASDAQ:NIHD), Cell Therapeutics Inc. (NASDAQ:CTIC), BlackBerry Limited (NASDAQ:BBRY)

% of readers think this story is Fact. Add your two cents.


With the Dow Jones Industrial Average (^DJI) currently at 16,348.27 descends triple digits -110.29 (0.67%) amongst New York Stock Exchange (^IXIC) Verizon Communications Inc. (NYSE:VZ) and Johnson & Johnson (NYSE:JNJ) earnings, we would advise you to take a look at NASDAQ Composite ticker symbol (NASDAQ:NIHD). NII Holdings Inc. stock has surged +4.67% Up 0.14 generating over thirteen point three million shares in the financial market at $3.12 per share Tuesday January 21, 2014 Real-time: 12:05PM EST. The Company (www.nii.com) is a provider of differentiated mobile communication services for businesses and high value consumers in Latin America. The topic of interest amongst investors surrounding NII Holdings Inc. is PRIP™, its advanced Push to Talk app.

PRIP™ is now available on the iPhone in the United States. This app provides users real-time, instant, unlimited communication using 3G, 4G or Wi-Fi to other PRIP subscribers and Nextel users throughout the U.S. NII Holdings Inc. is a great versatility company. Not only does its inked agreement with Telefonica S.A. display that, but also its offering of iPhone 5s and iPhone 5c to Nextel Brazil customers by the end of January 2014. Wall Street analysts always favor versatility in the stock market.

Up next in the NASDAQ Composite is ticker symbol (NASDAQ:CTIC). Cell Therapeutics Inc. stock has surged +10.99% Up 0.40 generating over sixteen point one million shares in the financial market at $4.04 per share Tuesday January 21, 2014 Real-time: 12:18PM EST. The Company (www.CellTherapeutics.com) is a biopharmaceutical company committed to the development and commercialization of an integrated portfolio of oncology products aimed at making cancer more treatable. The topic of interest amongst investors surrounding Cell Therapeutics, Inc. is its 2013 outlook favoring GOG-0212 Phase 3 maintenance therapy trial for patients with ovarian cancer finishing enrollment in the first quarter 2014 and partner pursuits for the commercialization of PIXUVRI outside of Western Europe.

Last but not least in the NASDAQ Composite is ticker symbol (NASDAQ:BBRY). BlackBerry Limited stock has surged +9.80% Up 0.89 generating over forty five point eight million shares in the financial market at $9.97 per share Tuesday January 21, 2014 Real-time: 12:23PM EST. The Company (http://www.blackberry.com) is a global leader in wireless innovation. The topic of interest amongst investors surrounding BlackBerry Limited is its completion of the purchase by Fairfax Financial Holdings Limited, through its subsidiaries, of an additional U.S.$250 million principal amount of 6% unsecured subordinated convertible debentures of BlackBerry. Keep in mind, that BlackBerry Limited’s partnership with Foxconn would allow the company to create low end BlackBerry devices.

Read Full Disclaimer at http://crweselect.com/disclaimer/

Remember: Always do your homework and consult your own financial professional.

Read Full Disclaimer



Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Lion’s Mane Mushroom

Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes:

Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.

Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.

Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.

Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.

Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.

Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules. Today Be 100% Satisfied Or Receive A Full Money Back Guarantee Order Yours Today By Following This Link.

Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.